Special Topic
Topic: Extracellular Vesicles in Alzheimer's Disease: Peripheral-Brain Communication, Neurodegeneration, and Therapeutic Opportunities
A Special Topic of Extracellular Vesicles and Circulating Nucleic Acids
ISSN 2767-6641 (Online)
Submission deadline: 20 Jun 2027
Guest Editors
Special Topic Introduction
Alzheimer's disease (AD) is the most common cause of dementia and represents a growing global health challenge. Although considerable research has focused on amyloid-β (Aβ) accumulation, tau pathology, synaptic dysfunction, and neuroinflammation, increasing evidence indicates that AD is also influenced by systemic metabolic, vascular, immune, and microbial disturbances. Extracellular vesicles (EVs), including exosomes and microvesicles, have emerged as important mediators of intercellular and interorgan communication via the transport of proteins, lipids, metabolites, and nucleic acids between peripheral organs and the central nervous system.
Recent advances have revealed the multifaceted roles of EVs in AD pathogenesis, including the propagation of Aβ and pathological tau, regulation of neuroinflammation, blood–brain barrier dysfunction, mitochondrial impairment, and synaptic alterations. In particular, EV-mediated communication along the gut–brain, liver–brain, and vascular–brain axes provides new insights into how peripheral metabolic disorders, gut microbiota, and systemic inflammation contribute to brain aging and neurodegeneration. These mechanisms may also extend to AD and related dementias (ADRD), including vascular dementia, dementia with Lewy bodies, frontotemporal dementia, and mixed dementia.
EVs also offer promising opportunities as minimally invasive biomarkers for early diagnosis, disease monitoring, and differential diagnosis. Advances in EV isolation, single-vesicle profiling, molecular characterization, and bioengineering have further expanded their potential as therapeutic delivery platforms. Stem cell-derived, microbiota-derived, and engineered EVs may provide innovative strategies to modulate neuroinflammation, promote neuronal repair, and restore brain homeostasis.
This Special Topic welcomes original research and reviews addressing EV biology, peripheral–brain communication, diagnostic applications, and therapeutic opportunities in AD and related dementias, fostering innovative approaches to understanding and treating neurodegenerative diseases.
We would particularly encourage the Special Topic to include, but not be limited to:
• EV biomarkers for early diagnosis and differential diagnosis of AD and ADRD;
• EV-mediated regulation of ApoE, tau, and amyloid processing;
• EVs in vascular dementia, cerebral small vessel disease, and mixed dementia;
• Stem cell-derived and engineered EVs for neuroprotection and brain repair;
• EV-associated miRNAs, tRNAs, lncRNAs, circRNAs, DNAs, proteins, lipids, and metabolites;
• Gut microbiota-derived EVs and host–microbiome communication;
• Mitochondrial-derived vesicles and metabolic dysfunction in neurodegeneration.
Keywords
Extracellular vesicles, Alzheimer's disease, dementia, amyloid, tau, ApoE, mitochondrion, neuroinflammation, neurodegeneration, biomarker, therapy
Submission Information
For Author Instructions, please refer to https://www.oaepublish.com/evcna/author_instructions
For Online Submission, please login at https://www.oaecenter.com/login?JournalId=evcna&IssueId=evcna26111210697
Submission Deadline: 20 Jun 2027
Contacts: Serena Zhao, Editor, [email protected]




